In addition, FOXD3 can repress the drug resistance of lung cancer cells in vitro and in vivo [8], which is in line with our results that overexpression of FOXD3 could attenuate the chemoresistance of OC cells to CP in vivo. Here, FOXD3 is linked to lung cancer.